Related Experiment Video
Updated: Jul 14, 2026
10:52
Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
[Patent ductus arteriosus closure using a new device: the Nit-Occlud device]
Ricardo Gamboa1, Francisco P Mollón, Raúl E Ríos-Méndez
1Sección de Cardiología y Hemodinamia Pediátrica del ICyCC, Fundación Favaloro, Buenos Aires, Argentina. rgamboa@ffavaloro.org
Revista Espanola De Cardiologia
|May 25, 2007
Summary
The Nit-Occlud device effectively closes patent ductus arteriosus in pediatric patients. This minimally invasive procedure shows high occlusion rates and safety across various ductus morphologies.
Area of Science:
- Cardiology
- Medical Devices
- Pediatric Surgery
Context:
- Patent ductus arteriosus (PDA) is a common congenital heart defect.
- Percutaneous closure is an alternative to surgical intervention.
- The Nit-Occlud device is a specific implant for PDA closure.
Purpose:
- To evaluate the safety and efficacy of the Nit-Occlud device for percutaneous patent ductus arteriosus closure.
- To assess occlusion rates and complications in a cohort of pediatric patients.
Summary:
- Twenty-eight patients underwent percutaneous PDA closure using the Nit-Occlud device.
- The median age was 1.8 years, with a median weight of 10.9 kg.
- Immediate occlusion was 53.5%, reaching 95.2% at 12 months and 100% by 18 months.
- One case of postsurgical recanalization occurred.
- Median follow-up was 20.5 months.
Impact:
- The Nit-Occlud device demonstrates effectiveness and safety for PDA closure.
- The device is suitable for various ductus arteriosus morphologies.
- Percutaneous closure offers a viable treatment option for pediatric PDA.
